Poliquistosis renal autosómica dominante: mecanismos moleculares y nuevas posibilidades terapéuticas
Rodríguez Pérez, JC; Torres, MJ.
Nefrología (Madr.)
; 26(6): 651-652, nov.-dic. 2006.
Artículo en Es | IBECS (España) | ID: ibc-054925
Documentos relacionados
Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease.
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease.
Molecular and structural basis of the dual regulation of the polycystin-2 ion channel by small-molecule ligands.
A novel monogenic preimplantation genetic testing strategy for sporadic polycystic kidney caused by de novo PKD1 mutation.
Glomerular hyperfiltration: part 2-clinical significance in children.
Molecular genetic diagnosis of kidney ciliopathies: Lessons from interpreting genomic sequencing data and the requirement for accurate phenotypic data.
A long-read sequencing and SNP haplotype-based novel preimplantation genetic testing method for female ADPKD patient with de novo PKD1 mutation.
What Is Autosomal Dominant Polycystic Kidney Disease?
Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease.
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy?